T1	Temporal_Concept 2 13	44-year-old
T2	Temporal_Concept 2 13	44-year-old
T3	Organism_Attribute 14 18	male
T4	Qualitative_Concept 14 18	male
T5	Disease_or_Syndrome 24 28	ESRD
T6	Qualitative_Concept 40 45	usual
T7	Finding 46 61	state of health
T8	Temporal_Concept 72 75	day
T9	Health_Care_Activity 79 94	hospitalization
T10	Functional_Concept 110 122	unresponsive
T11	Finding 110 122	unresponsive
T12	Finding 127 136	pulseless
T13	Functional_Concept 144 158	hemodialysis .
T14	Therapeutic_or_Preventive_Procedure 144 158	hemodialysis .
T15	Medical_Device 162 194	automated external defibrillator
T16	Functional_Concept 199 205	placed
T17	Spatial_Concept 199 205	placed
T18	Activity 199 205	placed
T19	Qualitative_Concept 213 221	received
T20	Qualitative_Concept 222 233	appropriate
T21	Pathologic_Function 234 239	shock
T22	Population_Group 251 260	transient
T23	Temporal_Concept 251 260	transient
T24	Finding 261 266	CPR .
T25	Therapeutic_or_Preventive_Procedure 261 266	CPR .
T26	Amino_Acid__Peptide__or_Protein 261 266	CPR .
T27	Enzyme 261 266	CPR .
T28	Functional_Concept 274 281	brought
T29	Health_Care_Related_Organization 289 309	emergency department
T30	Spatial_Concept 314 321	further
T31	Occupation_or_Discipline 322 334	management .
T32	Health_Care_Activity 322 334	management .
T33	Occupational_Activity 322 334	management .
T34	Occupation_or_Discipline 339 346	history
T35	Functional_Concept 339 346	history
T36	Finding 339 346	history
T37	Organism_Attribute 339 346	history
T38	Conceptual_Entity 339 346	history
T39	Functional_Concept 347 355	included
T40	Finding 356 370	hypertension ,
T41	Disease_or_Syndrome 356 370	hypertension ,
T42	Disease_or_Syndrome 371 394	hepatitis C infection ,
T43	Disease_or_Syndrome 395 433	human immunodeficiency virus infection
T44	Plant 436 444	anemia ,
T45	Disease_or_Syndrome 436 444	anemia ,
T46	Disease_or_Syndrome 449 480	secondary hyperparathyroidism .
T47	Functional_Concept 484 493	arrival ,
T48	Activity 484 493	arrival ,
T49	Finding 501 523	hemodynamically stable
T50	Finding 528 537	euvolemic
T51	Health_Care_Activity 541 547	exam .
T52	Functional_Concept 548 555	Initial
T53	Idea_or_Concept 548 555	Initial
T54	Qualitative_Concept 548 555	Initial
T55	Temporal_Concept 548 555	Initial
T56	Idea_or_Concept 556 571	laboratory data
T57	Qualitative_Concept 572 580	revealed
T58	Quantitative_Concept 584 595	uncorrected
T59	Pharmacologic_Substance 596 603	calcium
T60	Inorganic_Chemical 596 603	calcium
T61	Biologically_Active_Substance 596 603	calcium
T62	Vitamin 596 603	calcium
T63	Element__Ion__or_Isotope 596 603	calcium
T64	Finding 607 611	1.65
T65	Intellectual_Product 607 611	1.65
T66	Quantitative_Concept 612 618	mmol/L
T67	Finding 621 627	normal
T68	Quantitative_Concept 621 627	normal
T69	Qualitative_Concept 621 627	normal
T70	Intellectual_Product 628 635	2.12.55
T71	Pharmacologic_Substance 647 662	ionized calcium
T72	Laboratory_Procedure 647 662	ionized calcium
T73	Element__Ion__or_Isotope 647 662	ionized calcium
T74	Biologically_Active_Substance 647 662	ionized calcium
T75	Element__Ion__or_Isotope 647 662	ionized calcium
T76	Finding 666 670	0.71
T77	Intellectual_Product 666 670	0.71
T78	Inorganic_Chemical 708 717	potassium
T79	Element__Ion__or_Isotope 708 717	potassium
T80	Pharmacologic_Substance 708 717	potassium
T81	Laboratory_Procedure 708 717	potassium
T82	Inorganic_Chemical 760 769	magnesium
T83	Element__Ion__or_Isotope 760 769	magnesium
T84	Pharmacologic_Substance 760 769	magnesium
T85	Element__Ion__or_Isotope 819 829	phosphorus
T86	Pharmacologic_Substance 819 829	phosphorus
T87	Quantitative_Concept 833 837	0.97
T88	Intellectual_Product 833 837	0.97
T89	Functional_Concept 874 881	Initial
T90	Idea_or_Concept 874 881	Initial
T91	Qualitative_Concept 874 881	Initial
T92	Temporal_Concept 874 881	Initial
T93	Finding 882 899	electrocardiogram
T94	Intellectual_Product 882 899	electrocardiogram
T95	Diagnostic_Procedure 882 899	electrocardiogram
T96	Spatial_Concept 882 899	electrocardiogram
T97	Animal 900 906	showed
T98	Finding 909 921	sinus rhythm
T99	Finding 929 950	prolonged QT interval
T100	Qualitative_Concept 955 962	diffuse
T101	Finding 963 969	T-wave
T102	Functional_Concept 970 977	changes
T103	Quantitative_Concept 970 977	changes
T104	Food 980 985	Fig .
T105	Medical_Device 986 990	1a )
T106	Intellectual_Product 986 990	1a )
T107	Quantitative_Concept 1000 1009	minutes ,
T108	Temporal_Concept 1000 1009	minutes ,
T109	Quantitative_Concept 1000 1009	minutes ,
T110	Temporal_Concept 1000 1009	minutes ,
T111	Finding 1023 1042	torsades de pointes
T112	Disease_or_Syndrome 1023 1042	torsades de pointes
T113	Intellectual_Product 1051 1055	1b )
T114	Functional_Concept 1067 1081	unresponsive .
T115	Finding 1067 1081	unresponsive .
T116	Finding 1095 1107	resuscitated
T117	Functional_Concept 1112 1123	transferred
T118	Health_Care_Related_Organization 1131 1152	intensive care unit .
T119	Idea_or_Concept 1131 1152	intensive care unit .
T120	Manufactured_Object 1131 1152	intensive care unit .
T121	Functional_Concept 1153 1162	Treatment
T122	Research_Activity 1153 1162	Treatment
T123	Therapeutic_or_Preventive_Procedure 1153 1162	Treatment
T124	Conceptual_Entity 1153 1162	Treatment
T125	Health_Care_Activity 1153 1162	Treatment
T126	Disease_or_Syndrome 1170 1199	secondary hyperparathyroidism
T127	Functional_Concept 1209 1218	initiated
T128	Idea_or_Concept 1209 1218	initiated
T129	Quantitative_Concept 1219 1220	3
T130	Finding 1219 1220	3
T131	Classification 1219 1220	3
T132	Temporal_Concept 1221 1226	years
T133	Event 1227 1232	prior
T134	Temporal_Concept 1227 1232	prior
T135	Laboratory_Procedure 1242 1283	intact parathyroid hormone ( iPTH ) level
T136	Quantitative_Concept 1292 1298	pmol/L
T137	Finding 1301 1307	normal
T138	Quantitative_Concept 1301 1307	normal
T139	Qualitative_Concept 1301 1307	normal
T140	Functional_Concept 1331 1339	included
T141	Pharmacologic_Substance 1340 1352	paricalcitol
T142	Organic_Chemical 1340 1352	paricalcitol
T143	Vitamin 1340 1352	paricalcitol
T144	Functional_Concept 1358 1370	hemodialysis
T145	Therapeutic_or_Preventive_Procedure 1358 1370	hemodialysis
T146	Temporal_Concept 1375 1380	daily
T147	Pharmacologic_Substance 1381 1393	cinacalcet .
T148	Organic_Chemical 1381 1393	cinacalcet .
T149	Temporal_Concept 1394 1405	Three weeks
T150	Temporal_Concept 1406 1414	prior to
T151	Health_Care_Activity 1415 1426	admission ,
T152	Pharmacologic_Substance 1431 1441	cinacalcet
T153	Organic_Chemical 1431 1441	cinacalcet
T154	Quantitative_Concept 1442 1446	dose
T155	Clinical_Attribute 1442 1446	dose
T156	Quantitative_Concept 1451 1460	increased
T157	Functional_Concept 1451 1460	increased
T158	Finding 1466 1468	60
T159	Functional_Concept 1469 1487	to 90 mg daily due
T160	Quantitative_Concept 1472 1474	90
T161	Finding 1472 1474	90
T162	Quantitative_Concept 1475 1519	mg daily due to an iPTH level of 85.6 pmol/L
T163	Temporal_Concept 1478 1483	daily
T164	Laboratory_Procedure 1494 1504	iPTH level
T165	Pharmacologic_Substance 1522 1529	calcium
T166	Inorganic_Chemical 1522 1529	calcium
T167	Biologically_Active_Substance 1522 1529	calcium
T168	Vitamin 1522 1529	calcium
T169	Element__Ion__or_Isotope 1522 1529	calcium
T170	Quantitative_Concept 1534 1538	2.11
T171	Finding 1534 1538	2.11
T172	Classification 1534 1538	2.11
T173	Quantitative_Concept 1539 1546	mmol/ L
T174	Element__Ion__or_Isotope 1551 1561	phosphorus
T175	Pharmacologic_Substance 1551 1561	phosphorus
T176	Conceptual_Entity 1588 1592	home
T177	Clinical_Attribute 1593 1604	medications
T178	Pharmacologic_Substance 1593 1604	medications
T179	Functional_Concept 1605 1613	included
T180	Pharmacologic_Substance 1614 1635	sevelamer carbonate ,
T181	Organic_Chemical 1614 1635	sevelamer carbonate ,
T182	Pharmacologic_Substance 1636 1646	nifedipine
T183	Organic_Chemical 1636 1646	nifedipine
T184	Geographic_Area 1647 1651	XL ,
T185	Pharmacologic_Substance 1656 1678	metoprolol succinate .
T186	Organic_Chemical 1656 1678	metoprolol succinate .
T187	Temporal_Concept 1679 1693	On admission ,
T188	Pharmacologic_Substance 1694 1704	cinacalcet
T189	Organic_Chemical 1694 1704	cinacalcet
T190	Qualitative_Concept 1709 1718	stopped ,
T191	Inorganic_Chemical 1723 1732	magnesium
T192	Element__Ion__or_Isotope 1723 1732	magnesium
T193	Pharmacologic_Substance 1723 1732	magnesium
T194	Inorganic_Chemical 1735 1746	potassium ,
T195	Element__Ion__or_Isotope 1735 1746	potassium ,
T196	Pharmacologic_Substance 1735 1746	potassium ,
T197	Laboratory_Procedure 1735 1746	potassium ,
T198	Pharmacologic_Substance 1751 1758	calcium
T199	Inorganic_Chemical 1751 1758	calcium
T200	Biologically_Active_Substance 1751 1758	calcium
T201	Vitamin 1751 1758	calcium
T202	Element__Ion__or_Isotope 1751 1758	calcium
T203	Functional_Concept 1764 1778	administered .
T204	Functional_Concept 1788 1795	factors
T205	Conceptual_Entity 1788 1795	factors
T206	Qualitative_Concept 1796 1803	capable
T207	Functional_Concept 1807 1815	inducing
T208	Laboratory_or_Test_Result 1816 1828	hypocalcemia
T209	Disease_or_Syndrome 1816 1828	hypocalcemia
T210	Finding 1834 1846	identified .
T211	Qualitative_Concept 1834 1846	identified .
T212	Finding 1851 1860	diagnosis
T213	Research_Activity 1851 1860	diagnosis
T214	Qualitative_Concept 1851 1860	diagnosis
T215	Finding 1864 1883	torsades de pointes
T216	Disease_or_Syndrome 1864 1883	torsades de pointes
T217	Qualitative_Concept 1884 1899	associated with
T218	Finding 1900 1921	prolonged QT interval
T219	Quantitative_Concept 1925 1929	part
T220	Spatial_Concept 1925 1929	part
T221	Functional_Concept 1930 1936	due to
T222	Pharmacologic_Substance 1937 1955	cinacalcet-induced
T223	Organic_Chemical 1937 1955	cinacalcet-induced
T224	Functional_Concept 1937 1955	cinacalcet-induced
T225	Intellectual_Product 1956 1962	severe
T226	Qualitative_Concept 1956 1962	severe
T227	Laboratory_or_Test_Result 1963 1975	hypocalcemia
T228	Disease_or_Syndrome 1963 1975	hypocalcemia
T229	Functional_Concept 1980 1986	made .
T230	Intellectual_Product 1987 1991	Once
T231	Temporal_Concept 1987 1991	Once
T232	Element__Ion__or_Isotope 1996 2014	total body calcium
T233	Fully_Formed_Anatomical_Structure 1996 2006	total body
T234	Anatomical_Structure 2002 2006	body
T235	Human 2002 2006	body
T236	Pharmacologic_Substance 2007 2014	calcium
T237	Inorganic_Chemical 2007 2014	calcium
T238	Biologically_Active_Substance 2007 2014	calcium
T239	Vitamin 2007 2014	calcium
T240	Element__Ion__or_Isotope 2007 2014	calcium
T241	Functional_Concept 2019 2029	replaced ,
T242	Clinical_Attribute 2034 2045	QT interval
T243	Clinical_Attribute 2034 2045	QT interval
T244	Research_Activity 2046 2056	normalized
T245	Finding 2064 2081	electrocardiogram
T246	Intellectual_Product 2064 2081	electrocardiogram
T247	Diagnostic_Procedure 2064 2081	electrocardiogram
T248	Spatial_Concept 2064 2081	electrocardiogram
T249	Spatial_Concept 2089 2096	further
T250	Finding 2097 2109	ar-rhythmias
T251	Functional_Concept 2115 2125	observed .
T252	Pharmacologic_Substance 2126 2143	Phosphate binders
T253	Pharmacologic_Substance 2148 2157	vitamin D
T254	Organic_Chemical 2148 2157	vitamin D
T255	Vitamin 2148 2157	vitamin D
T256	Biologically_Active_Substance 2158 2165	sterols
T257	Organic_Chemical 2158 2165	sterols
T258	Pharmacologic_Substance 2158 2165	sterols
T259	Occupation_or_Discipline 2186 2196	management
T260	Health_Care_Activity 2186 2196	management
T261	Occupational_Activity 2186 2196	management
T262	Disease_or_Syndrome 2201 2230	secondary hyperparathyroidism
T263	Patient_or_Disabled_Group 2234 2242	patients
T264	Disease_or_Syndrome 2248 2254	ESRD .
T265	Pharmacologic_Substance 2255 2265	Cinacalcet
T266	Organic_Chemical 2255 2265	Cinacalcet
T267	Temporal_Concept 2270 2278	recently
T268	Functional_Concept 2279 2289	introduced
T269	Conceptual_Entity 2296 2307	alternative
T270	Functional_Concept 2308 2316	option ,
T271	Idea_or_Concept 2308 2316	option ,
T272	Occupational_Activity 2317 2324	working
T273	Gene_or_Genome 2333 2357	calcium sensing receptor
T274	Receptor 2333 2357	calcium sensing receptor
T275	Amino_Acid__Peptide__or_Protein 2333 2357	calcium sensing receptor
T276	Activity 2361 2370	enhancing
T277	Functional_Concept 2375 2389	sensitivity to
T278	Cell_Component 2390 2403	extracellular
T279	Pharmacologic_Substance 2404 2411	calcium
T280	Inorganic_Chemical 2404 2411	calcium
T281	Biologically_Active_Substance 2404 2411	calcium
T282	Vitamin 2404 2411	calcium
T283	Element__Ion__or_Isotope 2404 2411	calcium
T284	Activity 2424 2434	inhibiting
T285	Functional_Concept 2439 2448	release .
T286	Quantitative_Concept 2439 2448	release .
T287	Therapeutic_or_Preventive_Procedure 2439 2448	release .
T288	Health_Care_Activity 2439 2448	release .
T289	Laboratory_or_Test_Result 2449 2461	Hypocalcemia
T290	Disease_or_Syndrome 2449 2461	Hypocalcemia
T291	Quantitative_Concept 2467 2473	common
T292	Functional_Concept 2467 2473	common
T293	Intellectual_Product 2467 2473	common
T294	Pathologic_Function 2474 2490	adverse effect ,
T295	Phenomenon_or_Process 2516 2525	mitigated
T296	Temporal_Concept 2533 2543	concurrent
T297	Functional_Concept 2544 2550	use of
T298	Pharmacologic_Substance 2551 2564	calcium-based
T299	Inorganic_Chemical 2551 2564	calcium-based
T300	Biologically_Active_Substance 2551 2564	calcium-based
T301	Vitamin 2551 2564	calcium-based
T302	Element__Ion__or_Isotope 2551 2564	calcium-based
T303	Functional_Concept 2551 2564	calcium-based
T304	Idea_or_Concept 2551 2564	calcium-based
T305	Inorganic_Chemical 2551 2574	calcium-based phosphate
T306	Pharmacologic_Substance 2551 2574	calcium-based phosphate
T307	Inorganic_Chemical 2551 2574	calcium-based phosphate
T308	Pharmacologic_Substance 2551 2574	calcium-based phosphate
T309	Pharmacologic_Substance 2565 2584	phosphate binders .
T310	Medical_Device 2575 2584	binders .
T311	Functional_Concept 2585 2596	Symptomatic
T312	Laboratory_or_Test_Result 2597 2609	hypocalcemia
T313	Disease_or_Syndrome 2597 2609	hypocalcemia
T314	Functional_Concept 2610 2617	induced
T315	Pharmacologic_Substance 2621 2631	cinacalcet
T316	Organic_Chemical 2621 2631	cinacalcet
T317	Gene_or_Genome 2635 2641	rare ,
T318	Qualitative_Concept 2635 2641	rare ,
T319	Temporal_Concept 2635 2641	rare ,
T320	Qualitative_Concept 2653 2659	OPTIMA
T321	Research_Activity 2660 2667	study ,
T322	Manufactured_Object 2660 2667	study ,
T323	Quantitative_Concept 2668 2672	only
T324	Intellectual_Product 2668 2672	only
T325	Patient_or_Disabled_Group 2678 2686	patients
T326	Idea_or_Concept 2687 2696	presented
T327	Laboratory_or_Test_Result 2704 2723	serum calcium level
T328	Laboratory_Procedure 2704 2723	serum calcium level
T329	Quantitative_Concept 2738 2743	mg/dL
T330	Quantitative_Concept 2746 2750	1.87
T331	Finding 2746 2750	1.87
T332	Classification 2746 2750	1.87
T333	Quantitative_Concept 2751 2759	mmol/L )
T334	Finding 2762 2783	Torsades de pointes ,
T335	Disease_or_Syndrome 2762 2783	Torsades de pointes ,
T336	Disease_or_Syndrome 2786 2831	polymorphic form of ventricular tachycardia ,
T337	Functional_Concept 2798 2802	form
T338	Qualitative_Concept 2798 2802	form
T339	Manufactured_Object 2798 2802	form
T340	Qualitative_Concept 2835 2839	seen
T341	Patient_or_Disabled_Group 2843 2851	patients
T342	Temporal_Concept 2857 2866	prolonged
T343	Cell 2867 2880	cardiomyocyte
T344	Intellectual_Product 2907 2916	exhibited
T345	Finding 2920 2937	electrocardiogram
T346	Intellectual_Product 2920 2937	electrocardiogram
T347	Diagnostic_Procedure 2920 2937	electrocardiogram
T348	Spatial_Concept 2920 2937	electrocardiogram
T349	Finding 2941 2948	long QT
T350	Temporal_Concept 2949 2960	intervals .
T351	Laboratory_or_Test_Result 2961 2975	Hypocalcemia ,
T352	Disease_or_Syndrome 2961 2975	Hypocalcemia ,
T353	Finding 2976 2989	hypokalemia ,
T354	Finding 2994 3008	hypomagnesemia
T355	Functional_Concept 3009 3017	increase
T356	Idea_or_Concept 3018 3022	risk
T357	Finding 3026 3045	torsades de pointes
T358	Disease_or_Syndrome 3026 3045	torsades de pointes
T359	Laboratory_or_Test_Result 3077 3089	Hypocalcemia
T360	Disease_or_Syndrome 3077 3089	Hypocalcemia
T361	Spatial_Concept 3090 3097	further
T362	Quantitative_Concept 3098 3107	increases
T363	Functional_Concept 3098 3107	increases
T364	Idea_or_Concept 3108 3112	risk
T365	Functional_Concept 3129 3140	development
T366	Physiologic_Function 3129 3140	development
T367	Organism_Function 3129 3140	development
T368	Temporal_Concept 3144 3149	early
T369	Patient_or_Disabled_Group 3176 3184	patients
T370	Finding 3185 3195	arrhythmia
T371	Functional_Concept 3200 3203	not
T372	Conceptual_Entity 3204 3211	resolve
T373	Laboratory_or_Test_Result 3222 3241	serum calcium level
T374	Laboratory_Procedure 3222 3241	serum calcium level
T375	Research_Activity 3242 3254	normalized ,
T376	Inorganic_Chemical 3265 3277	electrolytes
T377	Pharmacologic_Substance 3265 3277	electrolytes
T378	Functional_Concept 3283 3293	replaced .
T379	Intellectual_Product 3301 3312	knowledge ,
T380	Quantitative_Concept 3325 3328	one
T381	Quantitative_Concept 3336 3341	first
T382	Qualitative_Concept 3336 3341	first
T383	Intellectual_Product 3342 3350	reported
T384	Health_Care_Activity 3342 3350	reported
T385	Clinical_Attribute 3342 3356	reported cases
T386	Intellectual_Product 3342 3356	reported cases
T387	Functional_Concept 3351 3356	cases
T388	Quantitative_Concept 3351 3356	cases
T389	Pharmacologic_Substance 3360 3378	cinacalcet-induced
T390	Organic_Chemical 3360 3378	cinacalcet-induced
T391	Functional_Concept 3360 3378	cinacalcet-induced
T392	Laboratory_or_Test_Result 3379 3391	hypocalcemia
T393	Disease_or_Syndrome 3379 3391	hypocalcemia
T394	Functional_Concept 3392 3404	resulting in
T395	Finding 3405 3424	torsades de pointes
T396	Disease_or_Syndrome 3405 3424	torsades de pointes
T397	Disease_or_Syndrome 3429 3445	cardiac arrest .
T398	Idea_or_Concept 3449 3460	recommended
T399	Health_Care_Related_Organization 3468 3492	pharmaceutical company ,
T400	Laboratory_or_Test_Result 3493 3506	serum calcium
T401	Laboratory_Procedure 3493 3506	serum calcium
T402	Laboratory_Procedure 3511 3533	ionized calcium levels
T403	Qualitative_Concept 3544 3552	measured
T404	Diagnostic_Procedure 3544 3552	measured
T405	Temporal_Concept 3562 3566	week
T406	Genetic_Function 3573 3583	initiation
T407	Functional_Concept 3573 3583	initiation
T408	Mental_Process 3573 3583	initiation
T409	Health_Care_Activity 3587 3602	dose adjustment
T410	Pharmacologic_Substance 3606 3618	cinacalcet .
T411	Organic_Chemical 3606 3618	cinacalcet .
T412	Intellectual_Product 3619 3623	Once
T413	Temporal_Concept 3619 3623	Once
T414	Quantitative_Concept 3626 3642	maintenance dose
T415	Qualitative_Concept 3652 3665	established ,
T416	Temporal_Concept 3666 3673	monthly
T417	Research_Activity 3674 3684	monitoring
T418	Health_Care_Activity 3674 3684	monitoring
T419	Laboratory_or_Test_Result 3688 3701	serum calcium
T420	Laboratory_Procedure 3688 3701	serum calcium
T421	Qualitative_Concept 3725 3735	importance
T422	Functional_Concept 3739 3748	adherence
T423	Spatial_Concept 3752 3756	oral
T424	Therapeutic_or_Preventive_Procedure 3757 3780	calcium supplementation
T425	Qualitative_Concept 3781 3790	as needed
T426	Temporal_Concept 3781 3790	as needed
T427	Finding 3801 3809	stressed
T428	Patient_or_Disabled_Group 3819 3829	patients .
T429	Functional_Concept 3830 3843	Abnormalities
T430	Congenital_Abnormality 3830 3843	Abnormalities
T431	Laboratory_or_Test_Result 3847 3862	serum potassium
T432	Laboratory_Procedure 3847 3862	serum potassium
T433	Inorganic_Chemical 3867 3878	magnesium (
T434	Element__Ion__or_Isotope 3867 3878	magnesium (
T435	Pharmacologic_Substance 3867 3878	magnesium (
T436	Finding 3885 3888	EKG
T437	Diagnostic_Procedure 3885 3888	EKG
T438	Animal 3889 3896	showing
T439	Qualitative_Concept 3897 3904	diffuse
T440	Finding 3905 3925	T wave abnormalities
T441	Finding 3930 3956	QT interval prolongation ;
T442	Intellectual_Product 3933 3941	interval
T443	Temporal_Concept 3933 3941	interval
T444	Medical_Device 3959 3974	cardiac monitor
T445	Diagnostic_Procedure 3959 3974	cardiac monitor
T446	Medical_Device 3975 3981	strips
T447	Quantitative_Concept 3975 3981	strips
T448	Clinical_Attribute 3992 3999	patient
T449	Patient_or_Disabled_Group 3992 3999	patient
T450	Disease_or_Syndrome 4008 4043	polymorphic ventricular tachycardia
T451	Idea_or_Concept 4044 4059	consistent with
T452	Finding 4060 4079	torsades de pointes
T453	Disease_or_Syndrome 4060 4079	torsades de pointes
T454	Idea_or_Concept 4101 4105	risk
T455	Finding 4110 4123	arrhythmias ,
T456	Temporal_Concept 4128 4135	monthly
T457	Therapeutic_or_Preventive_Procedure 4136 4162	monitoring of electrolytes
T458	Geographic_Area 4163 4165	to
T459	Enzyme 4163 4165	to
T460	Qualitative_Concept 4163 4165	to
T461	Amino_Acid__Peptide__or_Protein 4163 4165	to
T462	Food 4166 4172	ensure
T463	Finding 4173 4205	normal serum levels of potassium
T464	Idea_or_Concept 4228 4241	recommended .
T465	Pharmacologic_Substance 4242 4252	Cinacalcet
T466	Organic_Chemical 4242 4252	Cinacalcet
T467	Finding 4263 4267	used
T468	Patient_or_Disabled_Group 4282 4290	patients
T469	Qualitative_Concept 4296 4301	known
T470	Quantitative_Concept 4302 4314	risk factors
T471	Intellectual_Product 4302 4314	risk factors
T472	Laboratory_or_Test_Result 4319 4333	hypocalcemia ,
T473	Disease_or_Syndrome 4319 4333	hypocalcemia ,
T474	Occupation_or_Discipline 4341 4348	history
T475	Functional_Concept 4341 4348	history
T476	Finding 4341 4348	history
T477	Organism_Attribute 4341 4348	history
T478	Conceptual_Entity 4341 4348	history
T479	Finding 4352 4369	QT prolongation ,
T480	Temporal_Concept 4379 4389	concurrent
T481	Functional_Concept 4390 4396	use of
T482	Quantitative_Concept 4403 4405	QT
T483	Chemical_Viewed_Functionally 4417 4425	agents .
T484	Intellectual_Product 4417 4425	agents .
T485	Pharmacologic_Substance 4417 4425	agents .
T486	Professional_or_Occupational_Group 4426 4433	Authors
T487	Activity 4434 4446	contribution
T488	Functional_Concept 4463 4469	access
T489	Spatial_Concept 4463 4469	access
T490	Medical_Device 4477 4481	data
T491	Idea_or_Concept 4477 4481	data
T492	Eukaryote 4477 4481	data
T493	Intellectual_Product 4488 4492	role
T494	Social_Behavior 4488 4492	role
T495	Conceptual_Entity 4488 4492	role
T496	Occupation_or_Discipline 4496 4503	writing
T497	Intellectual_Product 4496 4503	writing
T498	Mental_Process 4496 4503	writing
T499	Intellectual_Product 4508 4520	manuscript .
T500	Manufactured_Object 4508 4520	manuscript .
